Literature DB >> 30674263

New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking.

Maia Merlani1, Vakhtang Barbakadze1, Lela Amiranashvili1, Lali Gogilashvili1, Vladimir Poroikov2, Anthi Petrou3, Athina Geronikaki3, Ana Ciric4, Jasmina Glamoclija4, Marina Sokovic4.   

Abstract

BACKGROUND: Phenolic acids (caffeic-, ferulic and p-coumaric acid) are widely distributed in the plant kingdom and exhibit broad spectrum of biological activities, including antimicrobial activity.
OBJECTIVE: The goal of this paper is the synthesis of some caffeic acid derivatives selected based on computer-aided predictions and evaluate their in vitro antimicrobial properties against Gram positive and Gram negative bacteria and also a series of fungi.
METHODS: In silico prediction of biological activity was used to identify the most promising structures for synthesis and biological testing, and the putative mechanisms of their antimicrobial action. The designed compounds were synthesized using classical organic synthesis methods. The antimicrobial activity was studied using microdilution method.
RESULTS: Twelve tested compounds have shown good antibacterial activity. Five out of twelve tested compounds appeared to be more active than the reference drugs ampicillin and streptomycin. Despite that all compounds exhibited good activity against all bacteria tested, the sensitivity of bacteria towards compounds in general was different. The evaluation of antifungal activity revealed that all compounds were more active than ketoconazole, while seven compounds (2, 3, 4, 5, 7, 8 and 12) appeared to be more active than bifonazole. Docking results indicate that gyrase inhibition is the putative mechanism of antibacterial action while the inhibition of 14α-demethylase may be responsible for antifungal action. Prediction of cytotoxicity by PROTOX showed that compounds are not toxic (LD50 1000-2000 mg/kg).
CONCLUSION: Thirteen compounds, from which six are new ones, were synthesized, and twelve compounds were tested for antimicrobial activity. The studied compounds appeared to be promising potent and non-toxic antimicrobials, which could be considered as leads for new pharmaceutical agents. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Antimicrobial activity; CYP51; Caffeic acid derivatives; Docking; Gyrase; PASS; Phenolic acids.

Mesh:

Substances:

Year:  2019        PMID: 30674263     DOI: 10.2174/1568026619666190122152957

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

1.  Benzylidene-carbonyl compounds are active against itraconazole-susceptible and itraconazole-resistant Sporothrix brasiliensis.

Authors:  Stefanie Bressan Waller; Marlete Brum Cleff; Márcia Kutscher Ripoll; Mário Carlos Araújo Meireles; Marina Themoteo Varela; João Paulo Dos S Fernandes
Journal:  Folia Microbiol (Praha)       Date:  2020-08-21       Impact factor: 2.099

2.  nor 3'-Demethoxyisoguaiacin from Larrea tridentata Is a Potential Alternative against Multidrug-Resistant Bacteria Associated with Bovine Mastitis.

Authors:  Ana Lizet Morales-Ubaldo; Manases Gonzalez-Cortazar; Adrian Zaragoza-Bastida; Martín A Meza-Nieto; Benjamín Valladares-Carranza; Abdulrahman A Alsayegh; Gaber El-Saber Batiha; Nallely Rivero-Perez
Journal:  Molecules       Date:  2022-06-05       Impact factor: 4.927

3.  Antifungal effects and active compounds of the leaf of Allium mongolicum Regel.

Authors:  Huan Qu; Zhen Guo; Li Ma; Xiu Zhang; Haijun Ma; Yang Chen
Journal:  Front Chem       Date:  2022-08-24       Impact factor: 5.545

4.  Enzymatic Synthesis and Antimicrobial Activity of Oligomer Analogues of Medicinal Biopolymers from Comfrey and Other Species of the Boraginaceae Family.

Authors:  Maia Merlani; Dieter M Scheibel; Vakhtang Barbakadze; Lali Gogilashvili; Lela Amiranashvili; Athina Geronikaki; Valentina Catania; Domenico Schillaci; Giuseppe Gallo; Ivan Gitsov
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.